𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhanced expression of transforming growth factor (TGF-β and its type I and type II receptors in human glioblastoma tissues

✍ Scribed by Yamada, N.; Iwasa, H.; Kato, M.; Miyazono, K.

Book ID
122560090
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
173 KB
Volume
99
Category
Article
ISSN
0303-8467

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhanced expression of transforming grow
Enhanced expression of transforming growth factor-β and its type-I and type-II receptors in human glioblastoma
✍ Naoshi Yamada; Mitsuyasu Kato; Hidetoshi Yamashita; Monica Nistér; Kohei Miyazon 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 889 KB

lmmunohistochemical studies of transforming growth factor$ (TGF-P) and its receptors have been carried out on 16 glioma tissues and compared with 5 cases of gliosis. Significantly higher expressions of TGF-PI, as well as type-I and type4 TGF-fl receptors (TpR-I and TPR-II, respectively), were observ

Dysregulated expression of transforming
Dysregulated expression of transforming growth factor β and its type-I and type-II receptors in basal-cell carcinoma
✍ Masutaka Furue; Mitsuyasu Kato; Koichiro Nakamura; Kiyoko Nashiro; Kanako Kikuch 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 256 KB 👁 1 views

In mammals, transforming growth factor-beta (TGF-beta) is found in 3 highly homologous isoforms that exert their effects via heteromeric complexes of type-I and type-II receptors (TbetaR-I and TbetaR-II). TGF-beta regulates the growth and metabolism of various cell types, including keratinocytes. We

Down-regulation of protein and mRNA expr
Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer
✍ Yanping Guo; Stephen C. Jacobs; Natasha Kyprianou 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 298 KB 👁 1 views

Transforming growth factor-b (TGF-b1) is a potent negative regulator of cell growth that transduces signals through interactions with type I and II receptors. Abnormal expression and mutational alterations of these receptors have been observed in several human malignancies. In this study, we investi